Research Summary
Analyzed using Evidence Intelligence™

CPAP treatment lowers daytime heart rate in prediabetes patients

Last updated August 16, 2026

Key finding

CPAP reduced daytime resting heart rate by 4.1 beats/min (95% CI, -6.5 to -1.7 beats/min; P = 0.002).

This study investigated the impact of Continuous Positive Airway Pressure (CPAP) on daytime resting heart rate in patients with obstructive sleep apnea and prediabetes, finding a significant reduction.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Short-Term (≤3 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study investigated the impact of Continuous Positive Airway Pressure (CPAP) on daytime resting heart rate in patients with obstructive sleep apnea and prediabetes, finding a significant reduction.

Clinical relevance

This finding is clinically significant as it suggests that CPAP therapy not only alleviates symptoms of obstructive sleep apnea but may also contribute to better cardiovascular health in patients with prediabetes. Reducing daytime resting heart rate can lower the risk of cardiovascular complications, making CPAP an important treatment option for this population.

Keep in mind

The study's sample size may limit the generalizability of the findings. The specific population studied may not represent all patients with obstructive sleep apnea. Potential confounding factors were not fully controlled for.

Published in

Journal Reference

Publication details and source links for this paper.

Sushmita P, Florian C, Kristen W, Harry W, Tamar P, Esra T. Continuous Positive Airway Pressure Treatment Reduces Daytime Resting Heart Rate in Patients with Obstructive Sleep Apnea and Prediabetes. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease. 2020;9(19):e016871. doi:10.1161/JAHA.120.016871

Main Effects

CPAP reduced daytime resting heart rate by 4.1 beats/min (P = 0.002).

Reduction in daytime resting heart rate correlated with decreased plasma norepinephrine (r = 0.44; P = 0.02).

Reduction in daytime resting heart rate correlated with decreased apnea-hypopnea index (r = 0.48; P = 0.005).

Reduction in daytime resting heart rate correlated with decreased oxygen desaturation index (r = 0.50; P = 0.003).

Reduction in daytime resting heart rate correlated with decreased microarousal index (r = 0.57; P < 0.001).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Continuous Positive Airway Pressure (CPAP) and Apnea Hypopnea Index (AHI), Decrease in Plasma Norepinephrine Levels, Heart rate, and 2 more.

Primary intervention

Continuous Positive Airway Pressure (CPAP)

Primary outcomes

  • Apnea Hypopnea Index (AHI)
  • Decrease in Plasma Norepinephrine Levels
  • Heart rate

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

5
Evidence pairs
5
Relationships
0
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 50

0

Related topics

5

Evidence pairs

0

Related studies

Why it is useful

  • Contributes to 5 evidence relationships
  • Includes primary outcome data
  • Linked to 0 direct semantic evidence topics

Core evidence

Study findings

The primary outcomes reported in this study.

Apnea Hypopnea Index (AHI)

Continuous Positive Airway Pressure (CPAP) → Apnea Hypopnea Index (AHI)

Continuous Positive Airway Pressure (CPAP) → Apnea Hypopnea Index (AHI)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Decrease in Plasma Norepinephrine Levels

Continuous Positive Airway Pressure (CPAP) → Decrease in Plasma Norepinephrine Levels

Continuous Positive Airway Pressure (CPAP) → Decrease in Plasma Norepinephrine Levels

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Heart rate

Continuous Positive Airway Pressure (CPAP) → Heart rate

Continuous Positive Airway Pressure (CPAP) → Heart rate

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Microarousal Index

Continuous Positive Airway Pressure (CPAP) → Microarousal Index

Continuous Positive Airway Pressure (CPAP) → Microarousal Index

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Oxygen Desaturation Index

Continuous Positive Airway Pressure (CPAP) → Oxygen Desaturation Index

Continuous Positive Airway Pressure (CPAP) → Oxygen Desaturation Index

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
25
Negative
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • CPAP led to a significant decrease in daytime resting heart rate by 4.1 beats/min.
  • Heart rate reduction correlated with decreased plasma norepinephrine levels.
  • Significant correlations were found with multiple indices related to sleep apnea.
who this applies

Who this applies to

  • Adults diagnosed with obstructive sleep apnea.
  • Individuals with prediabetes.
keep in mind

Keep in Mind

  • Results may not apply to populations outside the study's demographic.
  • Further research is needed to confirm long-term benefits of CPAP on cardiovascular health.
  • The study did not account for all potential confounding variables.
between the lines

Between the Lines

  • The study's sample size may limit the generalizability of the findings.
  • The specific population studied may not represent all patients with obstructive sleep apnea.
  • Potential confounding factors were not fully controlled for.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Continuous Positive Airway Pressure (CPAP) and Apnea Hypopnea Index (AHI), Continuous Positive Airway Pressure (CPAP) and Heart rate.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Continuous Positive Airway Pressure (CPAP) improve apnea hypopnea index (AHI)?

Emerging Evidence

Continuous Positive Airway Pressure (CPAP) appears to improve apnea hypopnea index (AHI).

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Apnea Hypopnea Index (AHI)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

What evidence is available on Continuous Positive Airway Pressure (CPAP) and decrease in plasma norepinephrine levels?

Emerging Evidence

Continuous Positive Airway Pressure (CPAP) appears to improve decrease in plasma norepinephrine levels.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Decrease in Plasma Norepinephrine Levels

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Continuous Positive Airway Pressure (CPAP) improve heart rate?

Emerging Evidence

Continuous Positive Airway Pressure (CPAP) appears to improve heart rate.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Heart rate

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Continuous Positive Airway Pressure (CPAP) improve microarousal index?

Emerging Evidence

Continuous Positive Airway Pressure (CPAP) appears to improve microarousal index.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Microarousal Index

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.